The DOI matches its Crossref record.
Mechanism by Which Psychotropic Drugs Inhibit Adenosine Cyclic 3',5'-Monophosphate Phosphodiesterase of Brain
Abstract
Bovine brain contains several molecular forms of adenosine cyclic 39,59-monophosphate phosphodiesterase. The activity of one of these forms is increased several fold by an endogenous protein activator. Chlorpromazine, a potent phenothiazine tranquilizer, specifically inhibits the activation of a partially purified phosphodiesterase prepared from bovine brain at concentrations which do not inhibit the enzyme in the absence of activator. Ethylene glycol bis(β-aminoethyl ether)-N,N9-tetraacetic acid (EGTA), a calcium chelator, also specifically inhibits the activation of phosphodiesterase. However, the mechanisms by which EGTA and chlorpromazine act are different. EGTA produces its effect by chelating calcium, a required cofactor for phosphodiesterase activation; the EGTA-induced inhibition can be overcome by increasing the calcium concentration but not by increasing the concentration of activator. In contrast, chlorpromazine inhibits the activation of phosphodiesterase by interfering with the phosphodiesterase-activator interaction; the chlorpromazine-induced inhibition can be overcome by increasing the concentration of activator but not by increasing the concentration of calcium. Several other psychotropic drugs also inhibit the activation of phosphodiesterase of bovine brain. The antipsychotic agents trifluoperazine, thioridazine, benperidol, pimozide, and chlorprothixene are all potent, selective inhibitors of the activation of phosphodiesterase. The antianxiety agents medazepam and chlordiazepoxide and the antidepressants amitriptyline, protriptyline, and desipramine also selectively inhibit the activation of phosphodiesterase but are significantly less potent than the antipsychotics. Phenothiazines with relatively weak antipsychotic actions, chlorpromazine sulfoxide and promethazine, are less selective and less potent inhibitors than the antipsychotic phenothiazine derivatives. Other agents having central pharmacological actions, such as pentobarbital, pipradrol, D-lysergic acid diethylamide, pentylenetetrazol, morphine, and amphetamine, are poor inhibitors of either the activated or unactivated phoshodiesterase. These findings suggest that (a) the mechanism by which the phenothiazines inhibit the activation of phosphodiesterase involves competition with the endogenous protein activator of phosphodiesterase, and (b) selective inhibition of the activation of phosphodiesterase is a property common to agents which are effective in certain forms of psychiatric illnesses rather than to either general central nervous system depressants or stimulants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Calmodulin Plays a Pivotal Role in Cellular Regulation
Cheung, W. Y. (1980) · Science · doi:10.1126/science.6243188 · Cited by 2,438
Structure of calmodulin refined at 2.2 Å resolution
Babu, Y. S., Bugg, C. E., & Cook, W. J. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90608-0 · Cited by 1,024
The role of adenosine and its nucleotides in central synaptic transmission
Phillis, J. W., & Wu, P. H. (1981) · Progress in Neurobiology · doi:10.1016/0301-0082(81)90014-9 · Cited by 764
Phosphodiesterase Isozymes: Molecular Targets for Novel Antiasthma Agents
TORPHY, T. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9708012 · Cited by 657
PHARMACOLOGICAL REGULATION OF CALMODULIN*
Weiss, B., Prozialeck, W., Cimino, M., Sellinger Barnette, M., & Wallace, T. L. (1980) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1980.tb29621.x · Cited by 340
Self-citation
Metadata
- Authors
- LEVIN, R. M., & WEISS, B.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 1976-07
- Volume
- 12
- Issue
- 4
- Pages
- 581-589
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2314940363
- Cited by
- 387
- References
- 0
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanism by Which Psychotropic Drugs Inhibit Adenosine Cyclic 3',5'-Monophosphate Phosphodiesterase of Brain. https://app.cochat.ai/papers/10.1016/s0026-895x(25)10787-6
- The paper
- LEVIN, R. M., & WEISS, B. (1976). Mechanism by Which Psychotropic Drugs Inhibit Adenosine Cyclic 3',5'-Monophosphate Phosphodiesterase of Brain. Molecular Pharmacology. https://doi.org/10.1016/s0026-895x(25)10787-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.